Phase I Radiation Dose-Escalation Study to Investigate the Dose-Limiting Toxicity of Concurrent Intra-Arterial Chemotherapy for Unresectable Hepatocellular Carcinoma

Concurrent intra-arterial chemotherapy and radiotherapy (iA-CCRT) can increase the response rate in hepatocellular carcinoma (HCC), but may cause a higher toxicity. We conducted this Phase I study to investigate the dose-limiting toxicity of iA-CCRT for HCC. In total, 52.5 Gy in 25 fractions was pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Yeona, Kim, Jun Won, Kim, Ja Kyung, Lee, Kwan Sik, Lee, Jung Il, Lee, Hyun Woong, Lee, Kwang-Hun, Joo, Seung-Moon, Lim, Jin Hong, Lee, Ik Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352219/
https://www.ncbi.nlm.nih.gov/pubmed/32570869
http://dx.doi.org/10.3390/cancers12061612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352219/
https://www.ncbi.nlm.nih.gov/pubmed/32570869
http://dx.doi.org/10.3390/cancers12061612

Ejemplares similares